Suppr超能文献

[转移性肾细胞癌的预后与转移模式的关系(作者译)]

[Prognosis of metastatic renal cell carcinoma related to the pattern of metastasis (author's transl)].

作者信息

Bohnenkamp B, Rhomberg W, Sonnentag W, Feldmann U

出版信息

J Cancer Res Clin Oncol. 1980 Jan;96(1):105-14. doi: 10.1007/BF00412901.

Abstract

Hundred nine unselected patients with metastatic renal cell carcinoma have been stratified into 3 groups according to their type of metastasis: 17 patients with sceletal involvement only, 67 patients with visceral metastases, and 21 patients with a mixed type of metastasis. Four patients with a locoregional pattern of recurrence were not included in the analysis. The survival data (evaluated by life table analysis and a modified Wilcoxon-Rang-test) revealed a better prognosis for patients presenting exclusively with osseous metastases compared to the group with visceral metastases. The patients with osseous metastases showed a median survival time from diagnosis of 29.9 months compared to 11.6 months in patients with visceral involvement. Considering only patients whose metastases have been detected after a period of latency post nephrectomy, there is a further increase in the survival in favour of the patients with sceletal metastases and the difference to the group with visceral metastases becomes statistically highly significant.

摘要

109例未经挑选的转移性肾细胞癌患者已根据转移类型分为3组:仅骨骼受累的患者17例,内脏转移的患者67例,以及混合型转移的患者21例。4例具有局部区域复发模式的患者未纳入分析。生存数据(通过生命表分析和改良的Wilcoxon秩和检验评估)显示,与内脏转移组相比,仅出现骨转移的患者预后更好。骨转移患者从诊断开始的中位生存时间为29.9个月,而内脏受累患者为11.6个月。仅考虑肾切除术后经过一段潜伏期才检测到转移的患者,骨骼转移患者的生存率进一步提高,与内脏转移组的差异在统计学上具有高度显著性。

相似文献

3
Bisphosphonates for breast cancer.用于乳腺癌的双膦酸盐类药物。
Cochrane Database Syst Rev. 2005 Jul 20(3):CD003474. doi: 10.1002/14651858.CD003474.pub2.
5
Bisphosphonates and other bone agents for breast cancer.用于乳腺癌的双膦酸盐及其他骨药物。
Cochrane Database Syst Rev. 2012 Feb 15(2):CD003474. doi: 10.1002/14651858.CD003474.pub3.
6
Bisphosphonates for breast cancer.用于乳腺癌的双膦酸盐类药物。
Cochrane Database Syst Rev. 2002(1):CD003474. doi: 10.1002/14651858.CD003474.
7
Predictors of early distant metastasis in women with breast cancer.乳腺癌女性早期远处转移的预测因素。
J Cancer Res Clin Oncol. 2013 Apr;139(4):645-52. doi: 10.1007/s00432-012-1367-z. Epub 2013 Jan 3.
8
Immunotherapy for advanced renal cell cancer.晚期肾细胞癌的免疫疗法。
Cochrane Database Syst Rev. 2005 Jan 25(1):CD001425. doi: 10.1002/14651858.CD001425.pub2.
9
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
10
Bisphosphonates and other bone agents for breast cancer.用于乳腺癌的双膦酸盐及其他骨治疗药物。
Cochrane Database Syst Rev. 2017 Oct 30;10(10):CD003474. doi: 10.1002/14651858.CD003474.pub4.

引用本文的文献

1
[Surgical treatment of osseous metastases of the pelvis].[骨盆骨转移瘤的外科治疗]
Unfallchirurg. 2004 May;107(5):420-8. doi: 10.1007/s00113-004-0754-6.

本文引用的文献

1
Parenchymal carcinoma of the kidney.肾实质癌
Br J Urol. 1949 Jun;21(2):128-51. doi: 10.1111/j.1464-410x.1949.tb10761.x.
4
Factors in the prognosis of carcinoma of the kidney.肾癌预后的相关因素。
J Urol. 1958 Feb;79(2):190-5. doi: 10.1016/S0022-5347(17)66257-8.
5
Renal cell carcinoma. Natural history and results of treatment.肾细胞癌。自然病史及治疗结果。
Cancer. 1970 Jan;25(1):26-40. doi: 10.1002/1097-0142(197001)25:1<26::aid-cncr2820250106>3.0.co;2-4.
6
Classification of patients with disseminated cancer of the breast.乳腺癌播散患者的分类
Cancer. 1969 Nov;24(5):861-9. doi: 10.1002/1097-0142(196911)24:5<861::aid-cncr2820240502>3.0.co;2-3.
10
Hormones in the treatment of metastatic renal cancer.激素在转移性肾癌治疗中的应用
J Urol. 1975 Nov;114(5):692-3. doi: 10.1016/s0022-5347(17)67119-2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验